3,5-Dimethyl-4-nitro-1H-pyrazole

3,5-Dimethyl-4-nitro-1H-pyrazole Suppliers list
Company Name: Nanjing Pope Bio-tech R&D Co., Ltd  Gold
Tel: 025-87138562 18951783565
Email: sales@popebiotech.com
Company Name: J & K SCIENTIFIC LTD.  
Tel: 18210857532 18210857532
Email: jkinfo@jkchemical.com
Company Name: TCI (Shanghai) Development Co., Ltd.  
Tel: 021-67121386
Email: Sales-CN@TCIchemicals.com
Company Name: Beijing HwrkChemical Technology Co., Ltd  
Tel: 89508211 18501085097
Email: sales.bj@hwrkchemical.com
Company Name: Jia Xing Isenchem Co.,Ltd  
Tel: 0573-85285100 18627885956
Email: isenchem@163.com

3,5-Dimethyl-4-nitro-1H-pyrazole manufacturers

3,5-Dimethyl-4-nitro-1H-pyrazole Basic information
Product Name:3,5-Dimethyl-4-nitro-1H-pyrazole
Synonyms:ART-CHEM-BB B001468;AKOS 90439;AKOS B001468;4-NITRO-3,5-DIMETHYL-1H-PYRAZOLE;3,5-DIMETHYL-4-NITRO-1H-PYRAZOLE;TIMTEC-BB SBB009217;5-23-05-00160 (Beilstein Handbook Reference);1H-Pyrazole,3,5-dimethyl-4-nitro-(9CI)
CAS:14531-55-6
MF:C5H7N3O2
MW:141.13
EINECS:
Product Categories:NITRO
Mol File:14531-55-6.mol
3,5-Dimethyl-4-nitro-1H-pyrazole Structure
3,5-Dimethyl-4-nitro-1H-pyrazole Chemical Properties
Melting point 125.0 to 129.0 °C
Boiling point 325°C(lit.)
density 1.339±0.06 g/cm3(Predicted)
storage temp. Sealed in dry,Room Temperature
form powder to crystal
pka10.75±0.50(Predicted)
color White to Almost white
λmax274nm(CHCl3)(lit.)
InChIInChI=1S/C5H7N3O2/c1-3-5(8(9)10)4(2)7-6-3/h1-2H3,(H,6,7)
InChIKeyOFQCJVVJRNPSET-UHFFFAOYSA-N
SMILESN1C(C)=C([N+]([O-])=O)C(C)=N1
CAS DataBase Reference14531-55-6(CAS DataBase Reference)
Safety Information
RTECS UQ6585000
HazardClass IRRITANT
HS Code 2933199090
MSDS Information
3,5-Dimethyl-4-nitro-1H-pyrazole Usage And Synthesis
UsesAs Pyrazoles compound, 3,5-Dimethyl-4-nitro-1H-pyrazole has the key structures in numerous compounds of therapeutic importance. Compounds containing this ring system are known to display diverse pharmacological activities, for example as antimalarial agents , anti-inflammatory agents, and against cardiovascular disease.[1]
Synthesis
3,5-Dimethyl-4-iodopyrazole

2033-45-6

3,5-Dimethyl-4-nitro-1H-pyrazole

14531-55-6

General procedure for the synthesis of 3,5-dimethyl-4-nitropyrazole from 3,5-dimethyl-4-iodopyrazole: 1. 3,5-dimethyl-4-iodopyrazole (1 mmol) was dissolved in tetrahydrofuran (THF, 10 mL). 2. Add Fuajasite catalyst (250 mg) to the above solution. 3. Concentrated nitric acid (density 1.52 g/cm3, 10 mL) was added slowly. 4. Stir the reaction mixture at room temperature until the reaction is complete. 5. 5. Upon completion of the reaction, the catalyst was filtered to recover the catalyst. 6. 6. The filtrate was extracted several times with dichloromethane. 7. 7. The organic phases were combined and concentrated in vacuum to remove the solvent to give 3,5-dimethyl-4-nitropyrazole.

References[1] Edward R T Tiekink,  James L Wardell,  Solange M S V Wardell. “3,5-Dimethyl-1-(4-nitro-phen-yl)-1H-pyrazole.” Acta crystallographica. Section E, Structure reports online 68 Pt 4 (2012): o1018.
Tag:3,5-Dimethyl-4-nitro-1H-pyrazole(14531-55-6) Related Product Information
Dacthal 3,5-Dimethylpyrazole Dimethyl carbonate Pyraclostrobin Dimethyl ether Pyrazole Dimethyl fumarate Dimethyl sulfate Zolpidem tartrate Dimethyl disulfide Dimethyl sulfoxide N,N-Dimethylformamide Ethane Zolpidem 4-Nitropyrazole Potassium hydrogen phthalate 5-Chloro-1,3-dimethyl-4-nitro-1H-pyrazole 1-Acetyl-3(5)-(heptafluoro-1-propyl)-5(3)-methyl-4-(nitro)pyrazole